This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Immunitybio, Inc.. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Wenzhao Li: Innovator in Cellular Therapy
Introduction
Wenzhao Li is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of cellular therapy. He holds two patents that showcase his innovative approaches to preparing natural killer (NK) cells from whole blood mononuclear cells. His work has the potential to revolutionize treatments in immunotherapy.
Latest Patents
Wenzhao Li's latest patents focus on the preparation of cord blood or peripheral blood NK cells without the need to isolate CD34+ hematopoietic stem cells or NK cells. The methods he developed utilize an enrichment process that incorporates antiCD16 agonist antibodies, antiCD3 antibodies, and N-803. Notably, these processes are designed to be adaptable into a fully automated production process, referred to as "GMP in a box."
Career Highlights
Wenzhao Li is currently associated with ImmunityBio, Inc., where he continues to advance his research in cellular therapies. His innovative methods have garnered attention for their efficiency and potential applications in clinical settings.
Collaborations
Wenzhao Li collaborates with notable colleagues, including Rohit Duggal and Ranjeet Sinha, who contribute to the research and development efforts at ImmunityBio, Inc.
Conclusion
Wenzhao Li's work in the field of cellular therapy exemplifies the impact of innovative thinking in medicine. His patents and ongoing research are paving the way for new treatment options in immunotherapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile